The current projects of the group can be summarised as follows, with some of the more common technologies and sample matrices highlighted:
- The immuno-metabolic characterisation of HIV infection, latency and disease progression (Dr. Aurelia Williams)
- Metabolic profiling of HIV-associated genes
- The metabolomics of HIV and associated comorbidities (e.g. cardiovascular disease)
-
Metabolomics investigation of blood tube components
- Serum/plasma analysis
- Cell lines
- GCxGC-TOFMS, LC-MS, and 1H-NMR metabolomics
-
Metabolomics of HIV, TB, and HIV/TB coinfection (Dr. Laneke Luies)
- Urine and serum (blood) analysis
- GCxGC-TOFMS, LC-MS, and 1H-NMR metabolomics
- Better our understanding of HIV, TB and HIV/TB coinfection via metabolic characterisation, to aid with the improvement of current diagnostic and treatment approaches
-
Neuroinflammatory-associated metabolism and metabolomics of TB meningitis (Dr. Shayne Mason)
- Cerebrospinal fluid, urine, and brain tissue analysis
- 1H-NMR and GCxGC-TOFMS metabolomics
- Improve upon the understanding of metabolic characterisation, earlier diagnosis, treatment and monitoring of TB meningitis in the paediatric population
-
Metabolomics of TB drugs (Prof. Du Toit Loots, Dr. Ilse Du Preez, and Dr. Adetomiwa Adeniji)
- Cell culture and urine analysis
- GCxGC-TOFMS metabolomics
- Determine the effectiveness, toxicity, and the mechanism of action of directly observed short-course treatment, anti-TB investigational compounds and potential anti-TB repurposed antibiotics
-
Metabolomics of sporting activities and recovery (Prof. Du Toit Loots, Dr. Laneke Luies, and Dr. Zinandré Stander)
- Serum sample analysis
- GCxGC-TOFMS and 1H-NMR metabolomics
- Elucidate the effects induced by a marathon and the unaided as well as beetroot-aided recovery thereof
-
TB/diabetes comorbidity metabolomics (Prof. Du Toit Loots, Dr. Shayne Mason, and Dr. Zinandre Stander)
- Urine analysis
- GCxGC-TOFMS and 1H-NMR metabolomics
- Characterisation of TB/diabetes comorbidity metabolic profiles and elucidation of the interlinking nature (metabolic) between these underlying diseases